How Tension Over Trump Fractured American Diabetes ResearchNew York TimesIt began with a protest at an American Diabetes Association conference. Now a resulting boycott has caused a scientific slowdown, with no end in sight. FDA tells GLP-1 makers to warn of potential vision loss side effectWashington PostThe Food and Drug Administration announced Monday that it is requiring manufacturers of GLP-1 medications to warn that they can increase the risk of vision loss.